New patent for Endo Ventures drug EPHEDRINE SULFATE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for EPHEDRINE+SULFATE
Annual Drug Patent Expirations for EPHEDRINE+SULFATE

Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Endo Ventures, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, and Sandoz Inc and, and is included in nine NDAs. It is available from ten suppliers. There is one patent protecting this drug.

This drug has one patent family member in one country.

The generic ingredient in EPHEDRINE SULFATE is ephedrine sulfate. Ten suppliers are listed for this compound. Additional details are available on the ephedrine sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top